Historical Stock Price
TSRO historical stock prices picture
TSRO (TSRO) has the following price history information. Looking back at TSRO historical stock prices for the last five trading days, on January 15, 2019, TSRO opened at $74.80, traded as high as $74.90 and as low as $74.80, and closed at $74.86. Trading volume was a total of 1.82M shares. On January 16, 2019, TSRO opened at $74.85, traded as high as $74.92 and as low as $74.83, and closed at $74.88. Trading volume was a total of 2.13M shares. On January 17, 2019, TSRO opened at $74.90, traded as high as $74.95 and as low as $74.90, and closed at $74.94. Trading volume was a total of 2.11M shares. On January 18, 2019, TSRO opened at $74.95, traded as high as $74.97 and as low as $74.94, and closed at $74.96. Trading volume was a total of 1.19M shares. On January 22, 2019, TSRO opened at $74.96, traded as high as $74.96 and as low as $74.96, and closed at $74.96. Trading volume was a total of 0 shares.

TSRO Historical Stock Prices By Date:

TSRO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into TSRO shares, starting with a $10,000 purchase of TSRO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 01/22/2019
Start price/share: $29.48
End price/share: $74.96
Dividends collected/share: $0.00
Total return: 154.27%
Average Annual Total Return: 21.38%
Starting investment: $10,000.00
Ending investment: $25,426.67
Years: 4.82
Date Open High Low Close Volume
01/15/2019 $74.80 $74.90 $74.80 $74.86 1.82M
01/16/2019 $74.85 $74.92 $74.83 $74.88 2.13M
01/17/2019 $74.90 $74.95 $74.90 $74.94 2.11M
01/18/2019 $74.95 $74.97 $74.94 $74.96 1.19M
01/22/2019 $74.96 $74.96 $74.96 $74.96 0
TESARO is a biopharmaceutical company focused on providing therapies to people facing cancer. Co.'s primary focus is to develop treatments for tumors using various approaches, including small molecules and immuno-oncology antibodies, as monotherapies or in combinations. Co.'s products are: ZEJULA® (niraparib), which is for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer; and VARUBI® (rolapitant), a neurokinin, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Co. is evaluating its immuno-oncology anti-tumor agents in combination studies with niraparib and other anti-tumor agents.
Date Close
01/15/2019$74.86
01/16/2019$74.88
01/17/2019$74.94
01/18/2019$74.96
01/22/2019$74.96
TSRO is categorized under the Healthcare sector; below are some other companies in the same sector:

TSRX Historical Stock Prices
TTHI Historical Stock Prices
TTNP Historical Stock Prices
TTOO Historical Stock Prices
TTPH Historical Stock Prices
TVTY Historical Stock Prices
TXMD Historical Stock Prices
TYME Historical Stock Prices
TZYM Historical Stock Prices
UHS Historical Stock Prices

Also explore: TSRO shares outstanding history

Email EnvelopeFree TSRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


TSRO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.